Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

ERCP vs laparoscopic choledochotomy for bile stones

Data in the latest Annals of Surgery suggest that the majority of secondary bile duct stones can be diagnosed at the time of cholecystectomy and cleared trans-cystically, with those failing having either choledochotomy or postoperative ERCP.

News image

fiogf49gjkf04

Dr Leslie Nathanson and colleagues prospectively evaluated the limitations of laparoscopic choledochotomy or postoperative endoscopic retrograde cholangiography (ERCP), for patients failing laparoscopic trans-cystic clearance.

The researchers also assessed whether these patients should have laparoscopic choledochotomy or postoperative ERCP.

Clinical management of bile duct stones found at laparoscopic cholecystectomy in the last decade has focused on pre-cholecystectomy detection with ERCP clearance in those with suspected stones.

This clinical algorithm successfully clears the stones in most patients, but no stones are found in 20% to 60% of patients.

Rare unpredictably severe ERCP morbidity can result in this group.

The researchers' reported of their initial experience with 300 consecutive patients with fluoroscopic cholangiography and intraoperative clearance.

The team demonstrated that, for the pattern of stone disease seen, 66% of patients' bile duct stones can be cleared via the cystic duct with reduction in morbidity vs 33% requiring choledochotomy or ERCP.

The team intraoperatively randomized patients across 7 metropolitan hospitals after failed trans-cystic duct clearance to either laparoscopic choledochotomy or postoperative ERCP.

The exclusion criteria included ERCP prior to referral for cholecystectomy, and severe cholangitis or pancreatitis requiring immediate ERCP drainage.

Other exclusion criteria were common bile ducts with a diameter of less than 7 mm, or if bilio-enteric drainage was required in addition to stone clearance.

Total operative time was 11 minutes longer in the choledochotomy group, with slightly shorter hospital stay
Annals of Surgery

The team used drain decompression of the cleared bile ducts in the presence of cholangitis.

An edematous ampulla was used by the researchers due to instrumentation or stone impaction and technical difficulties from local inflammation and fibrosis.

The ERCP occurred prior to discharge from hospital, and mechanical or extracorporeal shockwave lithotripsy was available.

The team reported that sphincter balloon dilation as an alternative to sphincterotomy to allow stone extraction was not used.

Major endpoints for the trial were operative time, morbidity, retained stone rate, reoperation rate, and hospital stay.

The team noted that from 1998 to 2003, 372 patients with bile duct stones had successful trans-cystic duct clearance of stones in 286, leaving 86 patients randomized into the trial.

The researchers found that total operative time was 11 minutes longer in the choledochotomy group, with slightly shorter hospital stay of 6 days versus 8 days.

Bile leak occurred in 15% of those having choledochotomy with similar rates of pancreatitis between the groups of 7% vs 9%.

Other results that were similar between the groups included retained stones at 2% vs 4%, reoperation both at 7%, and overall morbidity of 17% vs 13%.

Dr Nathanson concludes, “These data suggest that the majority of secondary bile duct stones can be diagnosed at the time of cholecystectomy and cleared trans-cystically, with those failing having either choledochotomy or postoperative ERCP.”

“However, because of the small trial size, a significant chance exists that small differences in outcome may exist.”

“We would avoid choledochotomy in ducts less than 7 mm measured at the time of operative cholangiogram and severely inflamed friable tissues leading to a difficult dissection.”

“We would advocate choledochotomy as a good choice for patients after Billroth 11 gastrectomy, failed ERCP access, or where long delays would occur for patient transfer to other locations for the ERCP.”

Ann Surg 2005: 242(2):188-92
28 July 2005

Go to top of page Email this page Email this page to a colleague

 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 23 February 2018 
Heavy metals on a gluten-free diet
 23 February 2018 
MRI and NAFLD
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers
 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us